SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-23-001163
Filing Date
2023-11-09
Accepted
2023-11-09 17:15:59
Documents
80
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q igcpharma20230930_10q.htm   iXBRL 10-Q 1019257
2 EXHIBIT 31.1 ex_594160.htm EX-31.1 14740
3 EXHIBIT 31.2 ex_594161.htm EX-31.2 14783
4 EXHIBIT 32.1 ex_594162.htm EX-32.1 7844
10 igcpharma_logo.jpg GRAPHIC 1863
11 igcpharma_smlogo.jpg GRAPHIC 1287
  Complete submission text file 0001185185-23-001163.txt   5641629

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA igc-20230930.xsd EX-101.SCH 51767
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE igc-20230930_cal.xml EX-101.CAL 41313
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE igc-20230930_def.xml EX-101.DEF 220798
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE igc-20230930_lab.xml EX-101.LAB 420381
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igc-20230930_pre.xml EX-101.PRE 233948
74 EXTRACTED XBRL INSTANCE DOCUMENT igcpharma20230930_10q_htm.xml XML 914592
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

IRS No.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-32830 | Film No.: 231393767
SIC: 2834 Pharmaceutical Preparations